![Nicholas Haft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Haft
Gründer bei
Delix Therapeutics, Inc.
Profil
Nicholas Haft is the founder of Delix Therapeutics, Inc. Mr. Haft is currently the Director at Arcos Ventures SPV LLC since 2015.
Formerly, Mr. Haft was an Independent Director at Finch Therapeutics Group, Inc. from 2020 to 2023.
Mr. Haft completed undergraduate education at The Wharton School of the University of Pennsylvania.
Aktive Positionen von Nicholas Haft
| Unternehmen | Position | Beginn |
|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Gründer | - |
Arcos Ventures SPV LLC | Vorstandsvorsitzender | 01.04.2015 |
Ehemalige bekannte Positionen von Nicholas Haft
| Unternehmen | Position | Ende |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Direktor/Vorstandsmitglied | 23.06.2023 |
Ausbildung von Nicholas Haft
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Arcos Ventures SPV LLC | |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Health Technology |
